A pilot study on the use of serum glyoxalase as a supplemental biomarker to predict malignant cases of the prostate in the PSA range of 4-20 ng/ml

BACKGROUND & OBJECTIVES: Serum prostate specific antigen (PSA) though most commonly used for diagnosis of prostate cancer lacks specificity. This study was aimed at exploring the use of serum glyoxalase as a supplemental biomarker to differentiate between malignant vs non-malignant diseases of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chavan, Sushant V., Chavan, Niraj R., Balaji, Anusha, Trivedi, Vatsala D., Chavan, Padma R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237243/
https://www.ncbi.nlm.nih.gov/pubmed/22089607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237243/
https://www.ncbi.nlm.nih.gov/pubmed/22089607

Ejemplares similares